Colon cancer used to feel like a worry for later-something to think about decades down the road. Not anymore. An estimated ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

New colorectal cancer screening recommendations, released today by the American Cancer Society, may help millions more Americans test for the disease. The updated guidelines will now allow for a blood ...

Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...

When Erica Barnell was an MD/PhD student at Washington University in St. Louis, she met a woman who had stage four colorectal cancer (CRC). The woman was only 52 years old—more than a decade younger ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

He was diagnosed with Stage 3B colorectal cancer. The cancer had spread to two lymph nodes. He then underwent six months of ...

As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...